Evidence map›Paper›PMID 30809370›Full record

ArticleChemical science2019

Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design.

Xiang Li, W David Tolbert, Hong-Gang Hu, Neelakshi Gohain, Yan Zou, Fan Niu, Wang-Xiao He, Weirong Yuan, Jia-Can Su, Marzena Pazgier and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Non-symmetric stapling of native peptides.Nature reviews. Chemistry · 2024
    Review
  7. Article
  8. Article
  9. Methodology of stable peptide based on propargylated sulfonium.Biochemistry and biophysics reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Xiang LiSchool of Pharmacy , Second Military Medical University , Shanghai 200433 , China.
W David TolbertInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Hong-Gang HuSchool of Pharmacy , Second Military Medical University , Shanghai 200433 , China.ORCID 0000-0003-0577-3021
Neelakshi GohainInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Yan ZouSchool of Pharmacy , Second Military Medical University , Shanghai 200433 , China.ORCID 0000-0002-0274-7365
Fan NiuInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Wang-Xiao HeInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Weirong YuanInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Jia-Can SuChanghai Hospital , Second Military Medical University , Shanghai 200433 , China . Email: drsujiacan@163.com.ORCID 0000-0001-7080-263X
Marzena PazgierInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.
Wuyuan LuInstitute of Human Virology and Department of Biochemistry and Molecular Biology , University of Maryland , School of Medicine , Baltimore , MD , USA . Email: mpazgier@ihv.umaryland.edu ; Email: wlu@ihv.umaryland.edu.ORCID 0000-0002-1098-7713
University of Maryland, Baltimore · USSecond Military Medical University · CN

Funding

Molecular Basis of Human Neutrophil alpha-Defensin FunctionR01AI061482 · NIAID · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI LU, WUYUAN · 2005 to 2009
$1.8M
Anticancer peptide therapeuticsR01CA219150 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI WANG, YIN · 2017 to 2022
$1.7M
D-peptide activators of p53 as anticancer therapeuticsR21CA167296 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI LU, WUYUAN · 2014 to 2015
$367k
NCI NIH HHS R01 CA219150NCI NIH HHS R21 CA167296NIAID NIH HHS R01 AI061482
6 · The paper itself

Abstract

Two major pharmacological hurdles severely limit the widespread use of small peptides as therapeutics: poor proteolytic stability and membrane permeability. Importantly, low aqueous solubility also impedes the development of peptides for clinical use. Various elaborate side chain stapling chemistries have been developed for α-helical peptides to circumvent this problem, with considerable success in spite of inevitable limitations. Here we report a novel peptide stapling strategy based on the dithiocarbamate chemistry linking the side chains of residues Lys(

Identifiers

PMID30809370
PMCPMC6357863
OpenAlexW2902780231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.